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Association of Intimate Partner Violence and Childhood
Sexual Abuse with Cancer-Related Well-Being in Women
Ann L. Coker, Ph.D.,1 Diane Follingstad, Ph.D.,2 Lisandra S. Garcia, M.P.H.,1 Corrine M. Williams, Sc.D.,1
Tim N. Crawford, M.P.H.,3 and Heather M. Bush, Ph.D.3
Abstract
Background: Limited evidence suggests that intimate partner violence (IPV) may be associated with poorer
cancer outcomes. We hypothesized that timing and type of IPV as well as childhood sexual abuse (CSA) may
negatively affect depression, perceived stress, and cancer-related well-being.
Methods: This was a cross-sectional study of women diagnosed with either breast, cervical, or colorectal cancer
in the prior 12 months included in the Kentucky Cancer Registry. Consenting women were interviewed by
phone (n = 553). Multivariate analysis of covariance (MANCOVA) was used to determine the association
between IPV (37% lifetime prevalence) and type, timing, and the range of correlated cancer-related well-being
indicators, adjusting for confounding factors.
Results: IPV ( p = 0.002) and CSA ( p = 0.03) were associated with the six correlated well-being indicators. Spe-
cifically, lifetime and current IPV were associated with lower Functional Assessment of Cancer Therapy-Breast
Cancer (FACT-B) ( p = 0.006) and Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale
(FACIT-SP) ( p = 0.03) scores, higher perceived stress at diagnosis ( p = 0.006), and depressive symptom scores at
diagnosis ( p < 0.0001), whereas CSA was associated with lower FACT-B ( p = 0.02), increased number of co-
morbid conditions ( p = 0.03), and higher current stress levels ( p = 0.04). Current and past IPV, as well as psy-
chologic abuse, were associated with poorer well-being among women with a recent cancer diagnosis.
Conclusions: Our results provide evidence that both IPV and CSA negatively influence cancer-related well-being
indicators. These data suggest that identification of lifetime IPV and other stressors may provide information
that healthcare providers can use to best support and potentially improve the well-being of female cancer
patients.
Introduction
There is now an impressive literature documentingthe physical1 and mental2 health effects of intimate
partner violence (IPV), yet little research has explored the ef-
fect of IPV on cancer care outcomes. The mechanisms by
which IPVmay influence cancer care outcomes have not been
thoroughly explored; Figure 1 provides a depiction of the
hypothesized route by which IPV may negatively influence
the cancer care continuum. Intimate relationships are ac-
cepted as an important module of the biopsychosocial system
for cancer survivors, influencing physical and psychologic
well-being.3 IPV or specific actions or inactions by partners
may directly influence the cancer care continuum by re-
stricting women’s ability to be screened for cancer at re-
commended intervals. Limits to screening may cause delays
in cancer detection and result in presentation at a later cancer
stage, thus limiting cancer treatment options. Avoiding
partner conflict was noted as an important reason for not re-
ceiving follow-up care amongwomenwith abnormal Pap test
results,4 and recent severe physical partner violence was as-
sociatedwith not receiving free follow-up care amongwomen
with preinvasive cervical lesions.5 Authors of a case report
indicate that IPV may lead to delays in cancer detection and
treatment.6 Women experiencing childhood sexual abuse
(CSA) have been shown to be significantly less likely to re-
ceive Pap testing at recommended intervals.7,8 Sexual and
physical IPVmay play a similar role in reducing the likelihood
of cancer screening.9–12
There is limited evidence suggesting that IPV may be as-
sociated with an increased rate of cancer.12 Modesitt et al.13
found that almost 50% of 101 women treated for breast,
1Department of Obstetrics and Gynecology, and 2Department of Psychiatry, College of Medicine, and 3Department of Biostatistics, College
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cervical, endometrial, or ovarian cancer reported a history of
physical or sexual violence by a partner, and 25% reported
CSA; current abuse was rare (2%). Based on population-
based estimates of IPV prevalence (25%),14 women with
cancer may be twice as likely to have experienced violence as
women in the general population. Both CSA and IPV have
been associated with having preinvasive15,16 and invasive
cervical cancer.17
IPV may indirectly cause poorer cancer outcomes, as
women experiencing IPV are less likely to have health in-
surance and more likely to have fewer transportation op-
tions.18,19 Women leaving abusive relationships are more
likely to live in poverty and have less education and fewer
employment options.20–24 Further, given the chronic nature
of IPV and associated stress, women experiencing lifetime
IPV may be more likely to have risk behaviors associated
with cancer (e.g., smoking, alcohol or other substance use,
poorer diet, less physical activity),18,25–27 symptoms of de-
pression or anxiety, and more limited social support net-
works to cope with cancer if diagnosed.28–30 Lastly, women
experiencing IPV are significantly more likely to have a
range of comorbid conditions or disabilities that may limit
their ability to receive cancer screening or follow-up care if
cancer is detected.31 This association may be bidirectional;
changes in women’s health status defined by a disability or
cancer diagnosis may put women at higher risk for abuse
and injury.32
In this report, we further investigate the association
between IPV and cancer care among women with cervi-
cal, breast, and colorectal cancers. We hypothesized that
female cancer patients who had experienced IPV (or CSA)
would have (1) lower scores, indicating poorer cancer-
related quality of life, (2) greater perceived stress and de-
pressive symptoms after diagnosis, and (3) more comorbid
conditions.
Materials and Methods
Participant recruitment
Women aged 18–79 diagnosed as an incident and primary
case of either breast, cervical, or colorectal cancer in the prior 12
months included in the Kentucky Cancer Registry (KCR) were
eligible for this study. KCR verified pathology reports and
contacted the patient’s physician to determine if there was any
reason why a patient should not be approached. Participants
whose physicians did not provide a reason not to contact them
were then sent a letter describing the study by KCR staff. The
letter invited women to provide their contact information
(name and phone number) on an enclosed card stamped and
addressed to KCR staff. Women could also indicate on the
same card that they did not wish further contact. KCR staff
calledwomenwho did not return the cards to ask if theywould
bewilling to talkwithUniversity of Kentucky (UK) researchers
about study participation. KCR staff provided the information
from those agreeing to participate to staff at the UK Survey
Research Center (SRC), who then called the women. When
womenwere reached by telephone, the interviewer carried out
the telephone introduction and obtained explicit verbal consent
before beginning the interview. Phone interviews were con-
ducted within 1 year of cancer diagnosis. This study was ap-
proved by the Institutional Review Board at the University of
Kentucky, protocol number 09-0685-F1V, and an NIH Certifi-
cate of Confidentiality was granted (MD-09-007). Data were
collected by telephone interview, with an average duration of
30 minutes; those completing the interview were offered US
$10.00 incentive for their participation.
FIG. 1. Conceptual model
depicting hypothesized
routes by which intimate
partner violence may nega-
tively influence cancer care
continuum.
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Measures
Demographic and cancer risk factors. We obtained in-
formation to characterize the demographic profile (Table 1) of
female cancer patients. Demographic factors are depicted in
Figure 1 as potential indirect mechanisms by which IPV may
impact hypothesized cancer care outcomes. These factors in-
clude the woman’s current marital status and relationship
status at cancer diagnosis, smoking status, monthly house-
hold income, educational attainment, and the woman’s sat-
isfaction in her relationship with friends (proxy of social
support). KCR staff provided data to characterize the cancer
site and the woman’s race.
Lifetime and current physical, sexual, psychologic IPV and
CSA. Information to describe IPV occurrence by type
(physical, sexual, psychologic) and timing (current or past
only) was obtained from the women. If IPV was disclosed,
follow-up questions were asked to determine which partner
was abusive (current partner, partner at diagnosis, first part-
ner, any other partner). The following three items were used
to assess physical IPV (response options: yes or no): (1) Has
any intimate partner ever shoved, grabbed, pushed, pinched,
slapped, shook you, thrown nondangerous objects at you not
done in a playful manner? (2) hit you with a fist, kicked you,
punched you, bitten you, slapped you hard, thrown you,
dragged you, hit you with an object, or used any other type of
physical force that could cause injuries? and (3) pointed a
weapon at you, beat you up, choked you or attempted to
strangle you, burned you, used a weapon or other dangerous
object on you, or used physical force to hurt you? The fol-
lowing two items were used to measure sexual IPV: (1) Has
Table 1. Demographic Profile of Cancer Patients by Lifetime Intimate Partner Violence History
Lifetime IPV Difference between Ever vs. Never IPV
Ever n = 205 Never n = 348 Testdf(p value)
Mean age (SD) 53.94 (11.90) 60.27 (10.43) t testdf = 1- 6.53 ( < 0.0001)
Current marital status
Married 122 (58.7%) 264 (73.1%) Chi-square df = 4 34.56
( < 0.0001)
Separated/divorced 52 (25.0%) 31 (8.6%)
Widowed 20 (9.6%) 50 (13.9%)
Never married 14 (6.7%) 16 (4.4%)
In a relationship within past
12 months: % Yes 151 (72.6%) 277 (76.7%) Chi-squaredf = 1 1.23
(0.27)
Race
Non-Hispanic white 194 (94.6%) 330 (94.8%) Chi-squaredf = 1 0.01
(0.62)
Nonwhite 11 (5.4%) 18 (5.2%)
Woman’s smoking status
Never smoker 107 (51.2%) 217 (60.1%)
Former smoker 71 (34.0%) 110 (30.5%)
Current smoker 31 (14.8%) 34 (9.4%) Chi-squaredf = 2 5.88
(0.05)
Woman’s monthly income
< $1000 32 (15.6%) 25 (7.2%)
$1000–$1999 36 (17.6%) 74 (21.2%)
$2000–$2999 65 (31.7%) 89 (25.6%)
$3000–$3999 23 (11.2%) 47 (13.5%)
$4000–$4999 20 (9.8%) 31 (8.9%)
‡ $5000 29 (14.1%) 82 (23.6%) Chi-squaredf = 5 17.82(0.003)
Woman’s educational attainment
Less than high school graduate 19 (9.3%) 37 (10.6%)
High school diploma or GED 67 (32.7%) 116 (33.3%)
Some college/vocational school 71 (34.6%) 101 (29.0%)
Bachelor’s degree 18 (8.8%) 42 (12.1%)
Postgraduate degree 30 (14.6%) 52 (14.9%) Chi-squaredf = 5 3.75
(0.93)
% History of childhood sexual abuse 41 (20.2%) 19 (5.5%) Chi-squaredf = 1 28.64
( < 0.0001)
Level of satisfaction with relationship with friends (proxy for social support)
Not satisfied 12 (6.0%) 3 (0.8%) Chi-squaredf = 2 12.41
(0.002)
Moderately satisfied 30 (14.9%) 56 (16.2%)
Very satisfied 159 (79.1%) 287 (83.0%)
Missing 4 2
Cancer site
Colorectal 25 (12.2%) 35 (10.0%) Chi-square df = 1 1.19
(0.27)
Breast 159 (77.6%) 302 (86.8%) REF
Cervical 21 (10.2%) 11 (3.2%) Chi-squaredf = 1 12.49
(0.0004)
Chi-square was used to compare ever, never lifetime partner abuse.
GED, general equivalency diploma; REF, referent; SD, standard deviation.
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any partner ever insisted on sexual activity that you did not
want to do? When you answer this question, please do not
include sexual activities that youwere physically forced to do.
[Interviewer could give these examples if asked: insisting on
having sex when he wanted it; insisting on particular sexual
behaviors like oral sex or anal sex that you did not want to
engage in.] (2) Has any partner ever physically forced you to
have sex or to engage in any sexual activities?
A modified version of the Measure of Psychologically
Abusive Behaviors (MPAB)33 and the Women’s Experience
with Battering Scale (WEB)34,35 were used to measure psy-
chologic abuse. The following three items devised from the
MPAB measured controlling behavior: (1) Has your partner
ever used behaviors to control you, such as getting upset if
you make even small decisions; dictating your personal
choices, such as what you wear; making major decisions
without you; acting upset to make you restrict your behavior
around others; trying to keep you from interacting with
members of the opposite sex; accusing you of having an
affair? (2) Has your partner ever done any of the following on
purpose to control you, such as ignoring important events,
withholding affection, refusing to speak to you, acting upset
or threatening to end the relationship to get you to do what
he/she wanted, or threatening to commit suicide until you
did what he/she wanted? (3) Has your partner ever tried to
keep track of you at all times, kept you away from your family
and friends, made you report on your whereabouts or activ-
ities, listened in on your phone calls, read your email or mail
when you did not want him to in order to control you? The
two questions devised from the MPAB measured intimidat-
ing behaviors: (1) Has your partner ever embarrassed you in
public on purpose, yelled or screamed, put you down, called
you mean names, or treated you as an inferior in order to
intimidate you? (2) Has your partner ever used threatening
behaviors toward you or harmed or destroyed your personal
things of value, harmed pets, or threatened to harm family/
children/friends to scare you?
Finally, the following three items from the WEB were used
to measure psychologic IPV by a current partner or the part-
ner at diagnosis: (1) Your partner made you feel like you have
no control over your life, no power, no protection. (2) You hid
the truth about your relationship from others because you
were afraid not to. (3) Your partner could scare you without
laying a hand on you. Response options ranged from strongly
disagree (0) to strongly agree (3), with total scores ranging
from 0 to 9.36 The following item measured CSA: Before age
18, did anyone ever physically force or attempt to physically
force you to do any sexual activity against your will?
Cancer well-being indicators (dependent variables). We
used 27-items from the Functional Assessment of Cancer
Therapy-Breast Cancer questionnaire23 (FACT-B) (alpha in
sample = 0.92, range 0–108, mean = 85.39; standard deviation
[SD] = 16.10), which measured physical functioning (7 items:
alpha in sample = 0.82, range 0–28, mean= 21.98, SD = 5.26),
social/family functioning (7 items: alpha in sample = 0.79,
range 0–28, mean= 22.79, SD= 4.83), emotional functioning (6
items: alpha in sample = 0.76, range 0–24, mean = 19.54,
SD = 3.99), and functional status (7 items: alpha in sam-
ple = 0.82, range 0–28, mean= 21.09, SD = 5.49). Two FACT-B
items assessing the patient’s relationshipwith her doctor were
excluded. We included the first 12 items from the Functional
Assessment of Chronic Illness Therapy-Spiritual Well-
being Scale (FACIT-Sp).37 Response options range from not at
all (0) to verymuch (4). The time frame for recall was the past 7
days; Cronbach’s alpha was 0.85 (range 0–48, mean= 39.49,
SD= 7.30).
We used three items from the 4-item Perceived Stress Scale
(PSS)38,39 to measure the cancer patients’ perceptions of their
stress during the 2–3 months after diagnosis and in the month
before the phone interview: (1) How often have you felt that
you were unable to control the important things in your life?
(2) How often have you felt confident about your ability to
handle your personal problems (reverse coded)? (3) How of-
ten have you felt difficulties were piling up so high that you
could not overcome them. The item excluded was: How often
have you felt that things were going your way? Response
options ranged from never (0) through very often (4). Higher
scores reflected greater perceived stress for the two separate
time intervals. The Cronbach alpha for the PSS-3 measure at
2–3 months postdiagnosis was 0.63 (range 0–12, mean= 4.37,
SD= 2.98) and for perceived stress in the month before inter-
view, the alpha was 0.60 (range 0–12, mean= 3.04, SD= 2.47).
Five items from the Brief Symptom Inventory (BSI-18)40
were used to measure depressive symptoms experienced
since the woman’s cancer diagnosis: Has there been a period
of at least 2 straight weeks in which most of the time (1) you
were down, depressed, or hopeless? (2) you experienced very
little interest or pleasure in doing things? (3) you had diffi-
culty sleeping and eating (that was not a result from any
medical treatment)? (4) you felt no energy, difficulty concen-
trating, feelings of worthlessness? (5) Since your cancer di-
agnosis, were you ever told by a medical doctor or mental
health professional that you were depressed? Response op-
tions were yes (1) or no (0). Cronbach alpha for the 5-item
measure was 0.78 (range 0–5, mean= 1.57, SD = 1.65).
Finally, women were asked if a doctor had ever told them
they had any of the following conditions: asthma, chronic
bronchitis, emphysema or chronic obstructive pulmonary
disease (COPD), high blood pressure or hypertension or high
cholesterol, heart disease or a heart attack, hepatitis or cir-
rhosis, diabetes, metabolic syndrome (IBS) or were insulin
resistant, irritable bowel syndrome or diverticulitis or diver-
ticulosis, fibromyalgia or chronic fatigue syndrome, and
stroke or a transient ischemic attack (TIA). Response options
for each condition were yes or no. Physical conditions were
summed to create an ordinal variable indicating the number
of conditions the woman has had.
Statistical analysis
Figure 1 served as a guide to this statistical analysis. IPV
was assessed by type (any, physical/sexual, or psychologic)
and by timing in separate models as measures of exposure.
CSA was included as another abuse exposure and a potential
confounder for IPV. We explored the direct pathway between
IPV and the cancer care continuum outcome of quality of life
measured with the FACT-B and FACIT. Other mental health
outcomes of relevance to quality of life (and depicted in Figure
1 through the indirect mechanism) included symptoms of
anxiety, depression, and number of comorbid health condi-
tions. Other attributes listed in Figure 1 as acting through the
indirect mechanism were treated in statistical models as
confounders and included socioeconomic indicators, risky
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health behaviors (i.e., smoking), and social support (i.e., sat-
isfaction with friends).
Demographic attributes of female cancer patients who re-
ported lifetime IPVwere comparedwith those of womenwho
disclosed no IPV to determine factors that may confound the
hypothesized association between IPV and the range of can-
cer-related well-being indicators (Table 1). Demographic fac-
tors were compared by lifetime IPV status and statistically
tested using either t test for continuous outcomes or chi-
square tests for categorical outcomes. Multiple analysis of
covariance (MANCOVA) was used to test all hypothesized
associations. Because age at diagnosis, marital status or cur-
rent relationship status, income, CSA, smoking, satisfaction
with relationships with friends, and cancer site were associ-
ated with lifetime IPV, all models were adjusted for these
potentially confounding factors.
The primary exposure, IPV, was categorized in three sep-
arate models: (1) ever vs. never experienced lifetime IPV
(Table 2), (2) current IPV and past IPV only both compared
with never experiencing IPV (timing analysis presented in
Table 3), and (3) sexual/physical IPV and psychologic IPV
alone, both compared with those never experiencing IPV (IPV
type presented in Table 3).
The six indicators of cancer-related well-being (FACT-B,
FACIT-Sp, PSS-3 in the past month, PSS-3 at 2–3 months after
diagnosis, depressive symptoms after diagnosis, and number
of comorbid conditions) were included in the MANCOVA
analysis. Additional MANCOVA analyses were conducted to
include each of the four FACT-B subscales and the remaining
measures of depressive symptoms, two stress measures, and
comorbid conditions (9 dependent variables). The F and p
values were obtained from the same MANCOVA model and
reported for IPVmeasures based on IPV timing and IPV type.
CSA was included in all models as a confounder for IPV and
as another violence exposure in the analyses.We provided the
Wilks’ Lambda Test Statistic for the MANCOVA model as a
test of the combined IPV and CSA exposures, adjusting for
confounders and considering all cancer-related well-being
outcomes. All analyses were conducted using SAS 9.2.
Results
From December 2009 to August 2011, the KCR was able to
contact 1903 (71.3%) of the 2668women eligible to participate in
this study. Forty-two percent (n= 1117) of women agreed to be
contacted by the SRC. Of these, 85.1%were reached by the SRC
(n= 951), and approximately 59.6% (n= 567) completed the in-
terview; 14 women declined to answer the IPV questions and
were excluded from the analysis. Nonrespondents (n= 567) did
not differ from respondents by age (t test= 1.14, p= 0.14), yet
nonrespondents weremore likely to be of nonwhite race (9.3%)
(chi-square= 6.54, p= 0.01) relative to respondents (5.3%), and
nonrespondents were less likely to be diagnosed with breast
cancer (77.5%) (chi-square= 6.04, p= 0.05). We had no other
demographic or cancer-related attribute with which to com-
pare nonresponders with responders.
In this sample of 553 women with either breast (n = 461,
83.3%), colorectal (n= 60, 10.9%), or cervical cancer (n = 32,
5.8%), the mean age was 57.9 years (SD= 11.4). Among wo-
men who reported being in a relationship at diagnosis, 10.6%
(44 women of 414) disclosed physical, sexual, or psychologic
IPV by a current partner or their partner at cancer diagnosis;
1.7% disclosed current physical IPV (n= 7); 0.2% reported
current sexual IPV (n = 1); and 10.1% (n = 42) disclosed current
psychologic IPV. Lifetime IPVwas disclosed by 37.1% (n = 205
of 553women), with 7.1% (n = 39) disclosing sexual IPV, 22.8%
(n= 126) disclosing physical IPV, and 34.5% (n= 191) disclos-
ing psychologic abuse. The overwhelming majority (91%) of
Table 2. Lifetime Intimate Partner Violence, Childhood Sexual Abuse, and Current Physical
and Mental Well-Being of Women Cancer Patients
Among all women cancer patients (n = 553)
Adjusted mean (standard error)a
Intimate partner violence childhood sexual abuse
Any IPV n = 205 Never n = 348 p value Ever n = 60 Never n = 493 p value
FACIT-Sp 38.91 (0.56) 40.22 (0.54) 0.03 39.65 (0.87) 39.47 (0.31) 0.85
FACT-B 81.65 (1.16) 85.16 (1.12) 0.006 81.16 (1.80) 85.65 (0.64) 0.02
Subscales of FACT-B
FACT-Physical 20.75 (0.40) 21.55 (0.40) 0.08 20.26 (0.64) 22.05 (0.23) 0.01
FACT-Social/Family 22.12 (0.34) 23.14 (0.33) 0.007 22.39 (0.53) 22.88 (0.19) 0.39
FACT-Emotional 18.73 (0.32) 19.70 (0.31) 0.006 18.96 (0.49) 19.47 (0.17) 0.33
FACT-Function 20.04 (0.41) 20.76 (0.40) 0.12 19.56 (0.64) 21.25 (0.23) 0.01
No. of Comorbid physical conditions 1.87 (0.10) 1.83 (0.10) 0.69 2.03 (0.16) 1.88 (0.06) 0.03
Perceived stress (PSS-3)
2–3 months postdiagnosis
5.10 (0.24) 4.38 (0.23) 0.006 5.03 (0.37) 4.46 (0.13) 0.16
Perceived stress (PSS-3)
during past month
3.64 (0.20) 3.18 (0.02) 0.04 3.75 (0.31) 3.07 (0.11) 0.04
Depression after diagnosis 2.15 (0.13) 1.50 (0.13) < 0.0001 2.02 (0.20) 1.63 (0.07) 0.07
Multiple analysis of covariance (MANCOVA) analyses.
aAdjusting for marital status, relationship status at diagnosis, income, childhood sexual abuse, age at diagnosis, smoking, social support,
cancer site, and (depending on the primary independent variable) childhood sexual abuse or IPV.
FACIT-Sp, Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale; FACT-B, Functional Assessment of Cancer
Therapy-Breast Cancer; PSS, perceived stress scale.
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those disclosing physical or sexual IPV also disclosed psy-
chologic abuse.
Sixty-one percent of women had at least one symptom of
depression after diagnosis, and 18% had four or more
symptoms. The majority (84.3%) had at least one comorbid
condition, and 50% had two or more conditions. Ten percent
of women scored as having high stress levels at diagnosis
(defined as responding often or very often to all PSS items),
and 2% responded as having high stress levels in the past
month using this same definition.
Table 1 shows the associations between lifetime IPV and
demographic attributes and other cancer risk factors. Relative
to women not disclosing IPV, women disclosing IPV were
significantly ( p£ 0.05) younger, less likely to be married, and
more likely to have lower monthly incomes, to smoke ciga-
rettes, to have a history of CSA, to be less satisfied with their
relationships with friends, and to have been diagnosed with
cervical cancer vs. breast or colorectal cancer.
Table 2 provides the results of MANCOVA analyses and
presents the adjusted means, standard deviation and p values
for cancer-related well-being outcomes. The MANCOVA test
results for both IPV and CSA were statistically significant
(IPV: Wilks’s Lambda= 0.96, F (6, 527)= 3.65, p= 0.002; CSA:
Wilks’s Lambda= 0.974, F (6, 527)= 2.37, p = 0.03), which in-
dicates that the null hypothesis, that IPV and CSA had no
overall effect on correlated outcomes indicative of cancer-re-
lated well-being, should be rejected. The models included all
correlated outcomes presented in Table 2 with the primary
dichotomous independent variables of (1) IPV and (2) CSA.
Note that separate models were run for FACT-B and four
subscales.
Briefly, when compared with never experiencing IPV,
lifetime IPV was significantly associated with lower FACT-B
scores (F = 7.51, p = 0.006), FACT-B subscales of social/family
(F= 7.22, p = 0.007) and emotional (F = 7.69, p = 0.006), FACIT-
Sp scores (F = 4.47, p= 0.03), and PSS scores immediately after
diagnosis (F = 7.50, p= 0.006), in the past month (F= 4.42,
p= 0.04), and with higher depressive symptom scores after
diagnosis (F= 20.56, p < 0.0001). When compared with never
experiencing CSA (n= 493) after adjustment for confounders
including IPV, CSA (n = 60) was associated with lower FACT-
B scores (5.39, p = 0.02), specifically FACT-physical (F= 6.81,
p= 0.01) and FACT-function subscales (F= 6.00, p= 0.01), more
comorbid physical conditions (F = 2.03, p = 0.03), and higher
PSS scores during the past month (F = 4.21, p = 0.04).
The statistically significant results ofMANCOVA for IPV by
timing (Wilks’s Lambda= 0.95,F (12, 1052)= 2.28, p= 0.008) and
IPV by type (Wilks’s Lambda= 0.938, F (12, 1052)= 2.86,
p= 0.0007) again indicated that IPV timing and type did have
an effect on these correlated outcomes. As presented in Table 3,
current IPV (n= 44) was associated with lower FACT-b social/
family (f= 13.13, p= 0.0003) and emotional subscale scores
(F= 7.33, p= 0.007), higher PSS scores for the past month
(F= 5.50, p= 0.02), and higher depressive symptom scores after
diagnosis (F= 8.08, p= 0.005). Past IPV (excluding current
abuse) was associated with lower FACT-emotional subscale
scores (F= 4.48, p= 0.03), higher PSS scores after diagnosis
(F= 6.61, p= 0.01), and higher depressive symptoms scores
(F= 17.08, p< 0.0001). Disclosing either physical or sexual IPV
(n= 133) was associated with lower FACT-emotional subscale
scores (F= 5.32, p= 0.02), higher PSS scores after diagnosis
(F= 4.74, p= 0.04), and higher depressive symptoms scores
(F= 18.96, p< 0.0001). Disclosing psychologic IPV (excluding
physical or sexual IPV) was associated with lower FACT-B
scores (F= 8.97, p= 0.003) and with FACT-B subscales for
social/family (F= 8.06, p= 0.005), emotional (F= 6.02, p= 0.01),
Table 3. Lifetime Intimate Partner Violence, by Timing and Type, and Current Physical
and Mental Well-Being of Female Cancer Patients
Among all women cancer cases (n = 553)
Adjusteda mean (standard error)p value
IPV timing IPV type
No IPVb
n = 348
Current IPV
n = 44
Past IPV alone
n = 161
Physical or sexual
IPV n= 133
Psychologic
IPV alone n = 72
FACIT-Sp 40.13 (0.36)REF 38.41 (1.01)0.11 38.95 (0.53)0.07 39.75 (0.60)0.53 37.27 (0.77)0.0008
FACT-B 86.91 (0.71)REF 81.11 (2.09)0.14 84.03 (1.11)0.08 84.42 (1.24)0.07 81.70 (1.61)0.003
Subscales of FACT-B
FACT-Physical 22.26 (0.26)REF 21.18 (0.74)0.17 21.54 (0.39)0.14 21.53 (0.44)0.16 21.33 (0.57)0.15
FACT-Social/Family 23.33 (0.22)REF 20.95 (0.62)0.0003 21.68 (0.33)0.10 22.61 (0.37)0.12 21.82 (0.48)0.005
FACT-Emotional 19.90 (0.20)REF 18.24 (0.57)0.007 19.11 (0.30)0.03 19.03 (0.34)0.02 18.75 (0.44)0.01
FACT-Function 21.42 (0.26)REF 20.74 (0.74)0.39 20.70 (0.29)0.14 21.24 (0.44)0.61 19.80 (0.47)0.007
No. of comorbid physical
conditions
1.68 (0.06)REF 1.54 (0.18)0.49 1.77 (0.10)0.45 1.81 (0.11)0.38 1.77 (0.10)0.45
Perceived stress in
2–3 months postdiagnosis
4.16 (0.15)REF 4.87 (0.43)0.12 4.88 (0.23)0.01 4.74 (0.26)0.04 4.88 (0.23)0.01
Perceived stress during
past month
2.92 (0.12)REF 3.81 (0.35)0.02 3.26 (0.19)0.14 3.13 (0.21)0.37 3.26 (0.19)0.14
Depression after diagnosis 1.34 (0.08)REF 2.06 (0.24)0.005 1.98 (0.12) < 0.0001 2.03 (0.14)< 0.0001 1.98 (0.12) < 0.0001
MANCOVA analyses.
aAdjusting for marital status, relationship status at diagnosis, income, childhood sexual abuse, age at diagnosis, smoking, social support,
and cancer site.
bNever IPV was the referent group.
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and function (F= 7.38, p= 0.007), lower FACIT-Sp scores
(F= 11.13, p= 0.0008), higher PSS scores at diagnosis (F= 7.64,
p= 0.006) and in the past month (F= 8.65, p= 0.003), and higher
depression scores at diagnosis (F= 9.36, p= 0.002).
Discussion
This is the first study to assess the association between IPV
and physical and mental health functioning among women
with a recent cancer diagnosis; we have no ability to compare
our results with others. However, findings from related
studies provide a context in which to view the current report.
IPV is well recognized as a strong predictor of anxiety and
depression,2 and cancer patients frequently experience
symptoms of depression and anxiety.41 We observed that
women who had ever experienced IPV were significantly
more likely to report depressive symptoms at cancer diag-
nosis relative to cancer patients never experiencing IPV. This
finding suggests that women’s depressive symptoms sur-
rounding a cancer diagnosis may be more directly associated
with IPV than with the cancer treatment alone.
Our observed rate of 24% of women cancer patients dis-
closing lifetime physical or sexual IPV was lower than that
reported by Modesitt et al.13 (50%). Similarly, our observed
rate of CSA was approximately half (11%) that reported by
Modesitt et al. (25%).12,13 Variances between the two studies
in the specific questions used to define IPV and CSA may
explain these rate differences. Our finding higher rates of
lifetime IPV among cervical cancer patients (67%) relative to
34% among breast cancer patients is consistent with an
emerging literature suggesting that IPV may be associated
with cervical cancer development.15–17
In this cross-sectional study, we cannot establish that IPV
and CSA caused poorer functioning subsequent to a cancer
diagnosis and treatment. However, stress theories have long
posited both direct and indirect effects of trauma experiences
on long-term mental and physical health problems.2 Self-se-
lection bias could explain study findings; however, this pat-
tern could occur only if women experiencing IPV were more
likely to participate in the study and report poorer function-
ing. This patterning is unlikely, as the proportion of women
reporting IPV in this studywas similar to national estimates of
25%,14 and our rates of IPV among women with cancer was
lower than that reported by Modesitt et al.13 Further, the
lifetime IPV rate of 36% observed in this cross-sectional study
is very comparable to the rates observed among respondents
to the Kentucky Women’s Health Registry survey of 35%
(lifetime physical, sexual, or psychologic IPV).17 Although
IPV and CSA misclassification is a plausible source of infor-
mation bias, the only source of data to characterize IPV was
the women’s own disclosure.
Strengths of this study include detailed information from
all women on the types and timing of IPV and CSA. All wo-
men included in the study were at risk of IPV because they
were in an intimate relationship at cancer diagnosis. We re-
duced confounding bias by collecting information on a wide
range of potentially confounding demographic factors as well
as other stressors and adjusted models for these factors. Fi-
nally, we addressed a range of correlated physical andmental
health dependent variables using MANCOVA.
We observed a strong association with both IPV and CSA
and cancer-related well-being. Well-being was operationalized
in this analysis as quality of life (FACT-B), which was part of
the cancer care continuum depicted in Figure 1. As has been
reviewed elsewhere,1 IPV may affect women’s health through
physical trauma, psychologic distress, or more subtle partner
controlling or interfering behaviors that may directly impact
women’s ability to obtain recommended care. Further, IPV
may indirectly affect health through the impact of IPV on
changing women’s income and educational trajectories.
Clearly, additional research is needed to better understand if
and how IPV directly and indirectly impacts cancer outcomes.
There are actions healthcare provider teams can do to re-
duce the impact of IPV at different junctures along the cancer
care continuum. For example, in Figure 1, IPV was hypothe-
sized to lead to women being diagnosed at a later cancer stage
because of lack of screening. We observed that psychologic
abuse was more strongly associated with cancer care out-
comes than was physical/sexual IPV. This finding strongly
suggests that (1) women will answer these questions and (2)
both forms of abuse do have consequences. This study’s
findings suggest that current IPV and past IPV and CSA affect
poorer functioning after a diagnosis of cancer, yet they appear
to have some unique differences with respect ot the func-
tioning they impact. Thus, screening and interventions must
address lifetime and current physical and psychologic forms
of IPV as well as CSA. This study has shown that all three
forms of IPV have clinical implications and these results re-
inforce recent recommendations from healthcare professional
organizations caring for women.42 Primary care providers can
potentially intervene by screening for both cancers and IPV.
Further along the cancer care continuum depicted in Figure 1
are receipt of suboptimal care and limited quality of life.
Addressing this aspect of cancer care may be best addressed
by the cancer care team. Further, clinical interventions require
training for providers to obtain skills to effectively and com-
passionately screen and intervene.
Screening for IPV and other forms of gender-based violence
is challenging in busy clinical settings.43 Clinical staff must be
well trained and receive administrative support for the time
required to screen and refer patients.43,44 Although the 2004
U.S. Preventive Services Task Force issued an ‘‘I’’ recommen-
dation, indicating insufficient evidence for or against family
violence including elder abuse and IPV,45 a recent compre-
hensive review of the effectiveness of screening concluded that
at least six screening tools were ‘‘highly accurate,’’ and several
trials of advocacy or counseling interventions reduced IPV.46
This review indicates that the required screening tools exist and
clinical interventions do improve violence outcomes for some
women. A recent Institute of Medicine report acknowledged
the evidence that IPV impacts women’s health and that inter-
ventions exist to improve outcomes when they recommended
that ‘‘all women and adolescent girls be screened and coun-
seled for interpersonal and domestic violence in a culturally
sensitive and supportive manner.’’47 The Affordable Care Act
now requires that health plans cover annual screening and
counseling for IPV.48 Although the American College of Ob-
stetricians andGynecologistis has been on record as supporting
IPV screening for women patients,49 these guidelines have yet
to be extended to care forwomenwith cancer. Our data suggest
that IPV and CSA can impact female cancer patients’ emo-
tional, social, and mental well-being. IPV screening and ap-
propriate referral and patient support could improve the well-
being of cancer patients.
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